MORGANTOWN, W.V., Jan. 15, 2015 (GLOBE NEWSWIRE) -- Protea Biosciences Group, Inc. (OTCQB:PRGB) (“Protea”) announced today that Purdue University has acquired Protea’s LAESI® DP-1000 Instrument System for direct molecular analysis. The system will be used in Purdue’s College of Agriculture, the Department of Botany and Plant Pathology, for the molecular imaging of herbicide active ingredients and other related compounds to optimize herbicide applications and improve weed management.
Protea’s LAESI system is a next generation molecular imaging platform that directly analyzes biological samples without the need to apply chemicals or introduce tags or tracers and enables 2-dimensional and 3-dimensional imaging, displaying the distribution of molecules in the samples.
“The continued investigation of how herbicides function within the plant’s morphological architecture and physiological pathways is paramount for improving the efficiency of herbicide activity and elucidating possible mechanisms that are the basis for the herbicide-resistant weeds impacting crop production, and Protea’s DP-1000 system will enable us to map and monitor specific compounds both on and within the plants of interest,” stated Bryan Young, PhD., Associate Professor of Weed Science in the Department of Botany and Plant Pathology at Purdue University. He continued, “Understanding the molecular interactions between plants and herbicides or combinations thereof is essential to developing strategies to combat invasive and emerging herbicide-resistant weed biotypes.”
“Collaborating with Purdue and applying our LAESI technology to the field of herbicide research is an important commercial sector for us,” stated Steve Turner, Protea’s CEO. “The discovery of novel herbicides can have a positive effect on crop production and ultimately the ability to more economically deliver food and livestock globally. In particular LAESI’s unique ability to provide three dimensional molecular analytics of plant tissues can be incredibly useful for mapping herbicides and other molecules within the leaf, to actually see the molecular changes that are occurring within plants.”
About Protea Biosciences Group, Inc.
Protea Biosciences (OTCQB:PRGB) is a molecular information company providing innovative bioanalytical solutions to the pharmaceutical, agricultural, and life science industries. Protea has developed a new, fully automated, molecular information technology platform, known as “LAESI” (Laser Ablation Electrospray Ionization), that enables the direct analysis of molecules without the need for sample preparation. Large molecular datasets are generated on native biological samples that can also be visually displayed as 2D and 3D images. Protea maintains its own laboratory facilities where services are provided to its clients, using LAESI and complementary technologies and expertise.
Forward-Looking Statements
This press release may contain statements relating to future results or events , which are forward - looking statements. Words such as “expects”, “intends,” “plans,” “may,” “could,” “should,” “anticipates,” “likely,” “believes” and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company’s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company’s control. It is possible that the Company’s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company’s business and financial and other results, are contained in the Company’s filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.
Protea and LAESI are registered trademarks of Protea Biosciences Group, Inc.
CONTACT: Protea Biosciences Group, Inc., 955 Hartman Run Road, Morgantown, WV 26505 USA Phone: 304.292.2226 Fax: 304.292.7101 haddon.goodman@proteabio.com https://proteabio.com/investors
Help employers find you! Check out all the jobs and post your resume.
